Monday February 02, 2015
As West Africa's devastating Ebola outbreak begins to dwindle, scientists are looking beyond the endgame at the kind of next-generation vaccines needed for a vital stockpile to hit another epidemic hard and fast.
Wednesday January 28, 2015
The EU has approved mega deals involving drugmakers Novartis and GlaxoSmithKline, provided they sell off assets in the vaccines and consumer health businesses.
Friday January 23, 2015
Liberia, once the centre of west Africa's deadly Ebola epidemic, has just five remaining confirmed cases of the disease, a senior health official said.
Friday December 05, 2014
GlaxoSmithKline has decided not to sell a portfolio of older drugs marketed in North America and Europe after considering offers from potential buyers.
Thursday November 27, 2014
US competition authorities have approved a pair of major deals in the medical field, including Medtronic's purchase of Covidien.
Wednesday November 26, 2014
An experimental Ebola vaccine made by GlaxoSmithKline has caused no serious side effects in an early trial, scientists reported in the New England Journal of Medicine.
Friday October 24, 2014
The World Health Organization (WHO) has set out plans for speeding up development of experimental Ebola vaccines, saying hundreds of thousands of doses should be ready for use in West Africa by the middle of 2015.
Thursday October 23, 2014
Tesco has reported pre-tax profits down over 90% to £112m in the six months to August.
Wednesday October 22, 2014
GlaxoSmithKline, battered by weak US drug sales and a bribery scandal in China, is looking to float its fast-growing HIV drugs business as part of a recovery plan that includes a fresh round of cost cutting.
Thursday September 25, 2014
Philip Hampton, who has been chairman of Royal Bank of Scotland since 2009, is to leave the bank next year for the same role at GlaxoSmithKline.